CisThera Inc. is a privately owned biopharmaceutical company in the Seattle area.  CisThera’s mission is to develop innovative therapeutics to treat  cancer, autoimmune diseases, as well as chronic kidney and liver diseases.  CisThera is taking a novel approach to identify drugs with greater efficacy that broadly inhibit validated contributors to disease pathogenesis.